Aravive Inc (ARAV)

NASDAQ
2.090
+0.090(+4.50%)
After Hours
2.070
-0.020(-0.957%)
- Real-time Data
  • Volume:
    176,433
  • Day's Range:
    1.920 - 2.160
  • 52 wk Range:
    0.580 - 2.400

ARAV Overview

Prev. Close
2
Day's Range
1.92-2.16
Revenue
7.67M
Open
2.03
52 wk Range
0.58-2.4
EPS
-2.33
Volume
176,433
Market Cap
125.04M
Dividend (Yield)
N/A
(N/A)
Average Vol. (3m)
136,931
P/E Ratio
-0.90
Beta
2.37
1-Year Change
-3.69%
Shares Outstanding
59,826,881
Next Earnings Date
Mar 31, 2023
What is your sentiment on Aravive?
or
Market is currently closed. Voting is open during market hours.

Aravive Inc News

Aravive Inc Analysis

Aravive Inc Company Profile

Aravive Inc Company Profile

Aravive, Inc. is a clinical-stage oncology company. The Company is focused on developing treatments designed to halt the progression of life-threatening diseases, including cancer and fibrosis. Its lead product candidate, AVB-500, is an ultrahigh-affinity, decoy protein that targets the GAS6-AXL signaling pathway associated with tumor cell growth, tumor metastasis, resistance to treatment, and decreased survival. The Company is evaluating AVB-500 in a registrational Phase III trial in platinum resistant ovarian cancer, a Phase Ib/2 trial in second line plus, clear cell renal cell carcinoma (ccRCC), and a Phase Ib/2 trial in first-line treatment of pancreatic adenocarcinoma. The Company’s lead candidate, Aravive-S6 (AVB-S6)-500, is a GAS6 binding protein and AXL decoy receptor. It is a Fc-fusion protein designed to block the activation of the growth arrest-specific 6 (GAS6)-AXL signaling pathway by intercepting the binding of GAS6 to its receptor AXL.

Read More

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong BuyStrong BuyStrong BuyStrong BuySell
Technical IndicatorsStrong BuyStrong BuyStrong BuyStrong BuyNeutral
SummaryStrong BuyStrong BuyStrong BuyStrong BuyNeutral
  • will be 25$ very soon!
    0
    • Moonshot!
      0